Singapore markets closed

SinoMab BioScience Limited (3681.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.890+0.040 (+2.16%)
At close: 03:50PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
1,365
0
25,913
0
-
Cost of revenue
943
943
0
-
-
-
Gross profit
422
422
0
-
-
-
Operating expenses
Research development
135,409
135,409
180,368
199,113
103,402
-
Selling general and administrative
97,615
97,615
82,591
133,400
72,010
-
Total operating expenses
229,997
229,997
258,927
331,769
162,652
-
Operating income or loss
-229,575
-229,575
-258,927
-305,856
-162,652
-
Interest expense
6,584
6,584
4,962
5,821
2,416
-
Income before tax
-243,111
-243,111
-284,158
-288,194
-122,600
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-243,111
-243,111
-284,158
-288,194
-122,600
-
Net income
-156,163
-243,111
-284,158
-288,194
-122,600
-
Net income available to common shareholders
-243,111
-243,111
-284,158
-288,194
-122,600
-
Basic EPS
-0.27
-
-0.29
-0.29
-0.12
-0.33
Diluted EPS
-0.27
-
-0.29
-0.29
-0.12
-0.33
Basic average shares
1,006,866
-
991,956
994,887
1,006,240
836,655
Diluted average shares
1,006,866
-
991,956
994,887
1,006,240
836,655